+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer



Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer



Geburtshilfe und Frauenheilkunde 75(7): 710-718



Aim: The risk of recurrence in breast cancer depends on factors such as treatment but also on the intrinsic subtype. We analyzed the risk factors for local, loco-regional and systemic recurrence, evaluated the differences and analyzed the risk of recurrence for different molecular subtypes. Material and Methods: A total of 3054 breast cancer patients who underwent surgery followed by adjuvant treatment at HSK hospital or Essen Mitte Hospital between 1998 and 2011 were analyzed. Based on immunohistochemical parameters, cancers were divided into the following subgroups: luminal A, luminal B (HER2-), luminal B (HER2+), HER2+ and TNBC (triple negative breast cancer). Results: 67 % of tumors were classified as luminal A, 13 % as luminal B (HER2-), 6 % as luminal B (HER2+), 3 % as HER2+ and 11 % as TNBC. After a median follow-up time of 6.6 years there were 100 local (3.3 %), 32 loco-regional (1 %) and 248 distant recurrences (8 %). Five-year recurrence-free survival for the overall patient collective was 92 %. On multivariate analysis, positive nodal status, TNBC subtype and absence of radiation therapy were found to be independent risk factors for all forms of recurrence. Age < 50 years, tumor size, luminal B (HER2-) subtype and breast-conserving therapy were additional risk factors for local recurrence. Compared to the luminal A subtype, the risk of systemic recurrence was higher for all other subtypes; additional risk factors for systemic recurrence were lymphatic invasion, absence of systemic therapy and mastectomy. Conclusion: Overall, the risk of local and loco-regional recurrence was low. In addition to nodal status, subgroup classification was found to be an important factor affecting the risk of recurrence. Fragestellung: Das Rezidivrisiko beim Mammakarzinom wird durch therapeutische Faktoren, aber auch durch den intrinsischen Subtyp beeinflusst. Diese Arbeit analysiert Risikofaktoren für lokales und lokoregionäres Rezidiv sowie systemische Rezidive, die Evaluation eventuell vorhandener Unterschiede sowie die Analyse des Rezidivrisikos in verschiedenen molekularen Subtypen. Material/Methoden: Analysiert wurden 3054 Patientinnen mit Mammakarzinom, die an den HSK-Wiesbaden und Kliniken Essen-Mitte zwischen 1998–2011 operiert und adjuvant behandelt wurden. Anhand immunhistochemischer Parameter erfolgte die Subgruppierung in Luminal A, Luminal B/HER2−, Luminal B/HER2+, HER2+ und TNBC. Ergebnisse: 67 % der Tumoren wurden als Luminal A, 13 % Luminal B/HER2−, 6 % Luminal B/HER2 +, 3 % HER2+ und 11 % TNBC kategorisiert. Nach einer medianen Nachbeobachtung von 6,6 Jahren traten 100 lokale (3,3 %), 32 lokoregionäre (1 %) Rezidive und 248 Fernmetastasen (8 %) auf. Das metastasenfreie 5-Jahres-Überleben für das Gesamtkollektiv betrug 92 %. In den multivariaten Analysen waren ein positiver Nodalstatus, der TNBC-Subtyp und die nicht durchgeführte Radiotherapie unabhängige Risikofaktoren für alle Rezidivformen. Für das Lokalrezidiv waren zudem Alter < 50 Jahre, Tumorgröße, Luminal B/HER2− und die brusterhaltende Therapie unabhängige Risikofaktoren. Das Risiko für systemische Rezidive war verglichen mit dem Luminal-A-Subtyp in allen weiteren Subtypen erhöht, neben dem Nachweis einer Lymphgefäßinvasion, nicht erfolgter Systemtherapie und Mastektomie. Schlussfolgerung: Insgesamt zeigt sich ein niedriges Risiko für lokale und lokoregionäre Rezidive. Neben dem Nodalstatus ist vor allem die Subgruppenklassifikation ausschlaggebend.

(PDF emailed within 0-6 h: $19.90)

Accession: 058634851

Download citation: RISBibTeXText

PMID: 26257408

DOI: 10.1055/s-0035-1546050


Related references

Loco-regional recurrence and survival after wide local excision, radiotherapy and axillary clearance for early breast cancer. Journal of the Royal Society of Medicine 85(8): 454-456, 1992

Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence. World Journal of Surgery 31(1): 36-45, 2006

The difference in prognostic factors between early recurrence and late recurrence in estrogen receptor-positive breast cancer: nodal stage differently impacts early and late recurrence. Plos One 8(5): E63510, 2014

Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence. European Journal of Cancer 31A(5): 690-698, 1995

Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma. Cancer 94(11): 2813-2820, 2002

Loco-regional recurrence following surgery of breast carcinoma: prognostic factors and therapeutic consequences. Schweizerische Medizinische Wochenschrift 118(52): 1976-1981, 1988

Oncotype Score as a Predictor of Local-Regional Recurrence in Early Stage Breast Cancer (BC). International Journal of Radiation Oncology*biology*physics 99(2): S54-S55, 2017

Predictors of systemic recurrence and impact of local failure among early stage breast cancer patients treated with breast conserving therapy. Breast Cancer Research & Treatment 69(3): 227, 2001

Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (< 40 years) women treated with breast conserving surgery first. Radiotherapy and Oncology 82(3): 272-280, 2007

Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first. Breast Diseases: A Year Book Quarterly 19(1): 65-66, 2008

Surgical margins and the risk of local-regional recurrence (LRR) following mastectomy for early-stage breast cancer. Journal of Clinical Oncology 29(27_suppl): 95-95, 2016

Prognostic Factors of Local-Regional Recurrence in Patients with Operable Breast Cancer in Asia: A Meta-Analysis. Open Access Macedonian Journal of Medical Sciences 7(4): 690-695, 2019

Outcome following local-regional recurrence in women with early-stage breast cancer: impact of biologic subtype. Breast Journal 21(2): 161-167, 2015

Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives. European Journal of Surgical Oncology 18(5): 442-448, 1992

Salvage treatment for loco-regional recurrence following breast conservation therapy for early breast cancer. European Journal of Surgical Oncology 17(3): 231-236, 1991